Olpasiran
amgen
['cardio', ' sun ', 'anheart']
open access: study design and rationale for the olpasiran trials of cardiovascular events and lipoprotein(a) reduction-dose finding study (ocean(a)-dose). #aha22 #cardiotwitter lbs.05. sun nov 6, 5-6pm 
The American Heart Journal has been a trusted resource for cardiologists and general practice physicians for more than 80 years